SCHEMBL5019549

SCHEMBL5019549

C[C@H](NC1=CC=NCN1)c1cc2cccc(Cl)c2c(N2CCN(C)CC2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 8/20 0.35
HTR6 P50406 2/20 0.32
HTR3B O95264 2/20 0.32
HTR3A P46098 2/20 0.32
CNR2 P34972 2/20 0.32
HRH3 Q9Y5N1 1/20 0.32
MEN1 O00255 1/20 0.31
MAPT P10636 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
DRD2 P14416 2/20 0.31
DRD3 P35462 1/20 0.31
ALK Q9UM73 1/20 0.31
HTR1A P08908 1/20 0.31
HTR2A P28223 1/20 0.31
HTR7 P34969 1/20 0.31
HTR3E A5X5Y0 1/20 0.31
HTR3D Q70Z44 1/20 0.31
HTR3C Q8WXA8 1/20 0.31
CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4569361 0.76 KCNN3 (0.38) HRH4CNR2SMN1; SMN2ALKHTR1A
SCHEMBL3695712 0.75 HRH4 (0.46) HRH4HTR6HTR3BHTR3AHRH3
SCHEMBL3700003 0.74 PIK3CD (0.41) HRH4CNR2HTR2A
SCHEMBL3700010 0.74 PIK3CD (0.41) HRH4CNR2HTR2A
SCHEMBL4569360 0.74 PIK3CD (0.51) HRH4CNR2CYP1A2CYP3A4CYP2D6
SCHEMBL4569362 0.71 PIK3CD (0.50) HRH4CNR2MEN1KMT2A
SCHEMBL16419892 0.69 ACHE (0.33) HTR2A
SCHEMBL4569356 0.67 PIK3CD (0.41) HTR2A
SCHEMBL3707240 0.67 FLT3 (0.45) CNR2MEN1KMT2ASMN1; SMN2CYP1A2
SCHEMBL20961866 0.66 PIK3CD (0.45) HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012064973-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2012-05-18 WO disclosed